Ku Lian Pi
Melia azedarach L. / Melia toosendan Sieb. et Zucc.
Also known as: Chinaberry bark(English) 苦楝皮(Chinese)
Goryeonpi苦楝皮 고련피 K'u Lien P'i
Updated October 5, 2026 · Not yet clinically reviewed
Safety at a glance
Graded toxic in our catalogue
Pregnancy: avoid — toxic
5 recorded drug interactions, 4 major or contraindicated
Contraindications or side effects are listed
Traditional Chinese Medicine
- Category
- anthelmintic
- Temperature
- Cold
- Taste
- Bitter
- Channels
- Liver,Spleen,Stomach
Functions
Expels Parasites; Kills Parasites and Eliminates Lice; Clears Damp-Heat from the Skin
Traditional uses
Ku Lian Pi (chinaberry bark, melia bark) is a cold, bitter, toxic herb used in Chinese medicine as a powerful antiparasitic agent — effective against roundworms, pinworms, and hookworms. It is also used externally for fungal skin conditions. Because of its toxicity, it must be used in carefully controlled doses, for short durations only, and under professional supervision. Liver function should be monitored with repeated use.
Western herbalism
Properties: antimicrobial
Formulas using this herb
4 of 4 formulas
- Dan Dao Qu Hui Tang 胆道驱蛔汤 · 15.00000g
- Hua Chong Wan 化虫丸 · deputy
- Lian Pi Sha Chong Wan · 6.00000g
- Shi Jun Zi San · 90.00000g
Botanical
Melia azedarach L. and the closely related Melia toosendan Siebold & Zucc. (Meliaceae), chinaberry or Persian lilac, are small to medium deciduous trees native to South and East Asia, reaching 7-15 m with bipinnate leaves, panicles of fragrant lilac flowers, and yellowish drupes about 1-1.5 cm in diameter that persist into winter. The medicinal Ku Lian Pi is the dried bark of the trunk, branches, or root, harvested in spring or autumn, longitudinally curled or in flat strips, grey-brown externally with longitudinal fissures and yellowish inner surface. It contains the limonoid triterpenes toosendanin (the principal anthelmintic constituent), azadirachtin-related compounds, and tannins. In traditional Chinese medicine, Ku Lian Pi is bitter and cold with toxicity, entering the spleen, stomach, and liver channels; it kills parasites and treats tinea, used internally for roundworm, pinworm, and hookworm infestation and topically for ringworm and scabies. It is hepatotoxic in overdose and must be used cautiously and not repeatedly. Also a major Ayurvedic herb (Mahanimba).
- Family
- Meliaceae
- Pharmaceutical name
- Cortex Meliae
- Parts used
- bark
- Plant type
- tree
Constituents
Toosendanin
Ring-C-seco triterpenoid limonoid · reported in the bark at up to roughly 0.5%; root bark is conventionally reckoned about twice as potent as stem bark
The pharmacopoeial marker of the drug and the compound that carries both its anthelmintic action and its toxicity. It can be isolated from only two species, Melia toosendan and Melia azedarach, which is why the Pharmacopoeia accepts both as the source of Ku Lian Pi. It is a presynaptic neuromuscular blocker: it first facilitates and then progressively depresses transmitter release at the neuromuscular junction and at central synapses, and this is the mechanism behind the neurological picture of Melia poisoning.
Kulinone
Tirucallane-type triterpenoid
A triterpenoid of the bark of Melia azedarach, reported alongside kulactone and 12-acetoxyamoorastatin. It is not used for standardisation and its contribution to the anthelmintic effect has not been established.
Kulactone
Triterpenoid lactone
A bark triterpenoid lactone characteristic of Melia azedarach. Like kulinone it is a marker of species identity rather than a therapeutically characterised principle.
12-Acetoxyamoorastatin
Limonoid
A limonoid isolated from Melia azedarach bark. It belongs to the same broad class as toosendanin and shares the general cytotoxic and insecticidal profile of the Melia limonoids.
Meliatoxins A1, A2, B1 and B2
Limonoid (meliatoxin type)
Ring-intact limonoids concentrated in the FRUIT of Melia azedarach rather than in the bark, and the fraction principally implicated in the fatal fruit poisonings of children and of dogs and pigs eating fallen fruit. Meliatoxin B1 is cytotoxic in the KB cell line. They are listed here because the fruit of this species is a recognised contaminant and substitute in the Melia trade, not because they are a normal constituent of correctly collected Cortex Meliae.
Nimbolinin B and 1-deacetylnimbolinin B
Nimbolinin-type limonoid
Additional limonoids reported from Melia species. More than 200 limonoids have now been isolated from the genus, and their collective pharmacology is dominated by cytotoxic, insecticidal and anti-botulism activity.
Condensed tannins
Tannin (polyphenol)
Present in the bark as in most bark drugs, contributing astringency. They are not the anthelmintic principle and have no bearing on the toxicity that governs how this drug is dosed.
Drug interactions
Chuan Lian Zi (Fructus Toosendan, the fruit of Melia toosendan)
Major · Substitution of the far more toxic Melia azedarach fruit for the pharmacopoeial Melia toosendan fruit; fatal paediatric poisonings are documented for the former · Evidence level: Probable
These are two different drugs from the same genus and they are routinely confused. Ku Lian Pi is the dried stem bark and root bark, and the Chinese Pharmacopoeia accepts both Melia toosendan and Melia azedarach as its source. Chuan Lian Zi is the fruit and is restricted to Melia toosendan. The fruit of Melia azedarach, sold as Ku Lian Zi, is the part in which the meliatoxins concentrate and is the material behind the reports of children killed by eating chinaberry fruit; Melia azedarach is generally reckoned the more toxic of the two species. When Ku Lian Zi is substituted for Chuan Lian Zi the patient receives a materially more dangerous drug under a name that implies the safer one. The species pairing in this record is therefore correct for the bark drug and must not be read across to the fruit drug.
Clinical note: Ku Lian Pi is not a duplicate of Chuan Lian Zi: different part, different species basis, different function. Never accept fruit when bark was ordered, and require the supplier to state the species and the plant part for any Melia product. Treat any Melia azedarach fruit material as unsuitable for dispensing.
Acetaminophen, isoniazid, methotrexate and other hepatotoxic drugs
Major · Additive hepatocellular injury; toxic hepatitis is part of the severe Melia poisoning syndrome · Evidence level: Probable
Severe Melia poisoning includes toxic hepatitis alongside internal haemorrhage, respiratory centre paralysis, mental disturbance, visual impairment, convulsions, coma and death. Milder poisoning presents 1 to 6 hours after ingestion with headache, dizziness, nausea, vomiting and abdominal pain. Toosendanin itself shows measurable cytotoxicity toward normal liver cells in vitro, and hepatotoxicity is the toxicity most consistently attributed to the Melia limonoids across the review literature. Children tolerate toosendanin less well than adults.
Clinical note: Do not combine Ku Lian Pi with other hepatotoxic agents. Keep to the pharmacopoeial dose of 4.5 to 9 g in decoction, use short courses only, and avoid the drug entirely in patients with existing liver disease, in pregnancy, and in young children unless there is no alternative and dosing is supervised.
Botulinum toxin injections and neuromuscular blocking agents
Major · Unpredictable interference with neuromuscular transmission; the herb both antagonises botulinum toxin and blocks transmission in its own right · Evidence level: Possible
Toosendanin is a well-characterised presynaptic agent. It makes rat cerebral synaptosomes completely resistant to botulinum neurotoxin A-mediated cleavage of SNAP-25, and even after the toxin has bound it still partially antagonises that cleavage; it also blocks translocation of the botulinum light chain through the heavy-chain channel. It is an effective treatment for experimental botulism for exactly this reason. But the same compound depresses transmitter release at the neuromuscular junction after an initial facilitation, and respiratory centre paralysis is part of the severe Melia poisoning picture. Both directions of the interaction are pharmacologically real: the herb may blunt a therapeutic botulinum toxin injection, and at toxic doses it contributes its own neuromuscular blockade.
Clinical note: Do not prescribe Ku Lian Pi around therapeutic or cosmetic botulinum toxin treatment. Avoid it in myasthenia gravis, in any patient on long-term neuromuscular blockade, and in any patient with respiratory muscle weakness.
Fatty meals, oil-based purgatives and lipid-containing vehicles
Moderate · Increased systemic absorption of the toxic limonoids · Evidence level: Theoretical
Toosendanin and the related Melia limonoids are lipophilic. The classical rule for anthelmintic drugs of this class is that they are taken on an empty stomach and that oily vehicles are avoided, the rationale being that the drug should act in the gut lumen on the parasite rather than be absorbed into the circulation. A lipid vehicle would be expected to increase systemic exposure and therefore toxicity. No pharmacokinetic study has quantified this for Melia bark, so it is a mechanistic inference consistent with long-standing practice rather than a measured effect.
Clinical note: Give on an empty stomach and avoid oil-based purgatives on the same day. Do not use castor oil to accelerate expulsion after a Melia anthelmintic.
Antiparasitic co-therapy in children
Major · Paediatric toxicity at doses adults tolerate · Evidence level: Probable
The classical indication for this drug, ascariasis and enterobiasis, is overwhelmingly a paediatric one, while the review and poisoning literature is explicit that children have lower tolerance to toosendanin than adults. The drug's therapeutic window is therefore narrowest in exactly the population it is traditionally aimed at, and this is compounded when it is combined with other agents that share a hepatic or neurological toxicity.
Clinical note: Modern anthelmintics such as albendazole and mebendazole are safer and better evidenced for confirmed ascariasis and enterobiasis in children. Ku Lian Pi should not be the first choice in a child, and should not be stacked with another antiparasitic.
Dosage
| Form | Amount | Frequency | Notes |
|---|---|---|---|
| decoction | 3–6 g | — | ChP 2025. Caution in pregnancy and in impaired liver or kidney function. Corrected from a generic 'As needed' poultice filler value generated from tcm_category. |
| topical | Appropriate amount | — | ChP 2025. 外用适量,研末,用猪脂调敷患处。 |
Evidence
Study design on record, not certainty of outcome.
- Observational / case report
- 1
- In vitro / animal
- 1
Human Melia azedarach poisoning
Dong Haur Phua, Wei-Jen Tsai, Jiin Ger, Jou-Fang Deng, Chen-Chang Yang · Clinical Toxicology · 2008 · case series
Observational / case report · Not yet verified
A poison-centre series of human poisonings specifically by Melia azedarach, not Melia toosendan. Neurological features dominated the presentation: weakness, myalgia, numbness and ptosis, consistent with the presynaptic neuromuscular action of toosendanin. Treatment was symptomatic and supportive and all patients in this series recovered without sequelae. The paper also reviews the animal toxicity literature, in which leaves, flowers and fruit have caused toxic effects in rats, and dogs and pigs have been poisoned by eating fallen fruit; although only the bark is the listed medicinal part, the whole plant appears to be toxic.
Antagonism of botulinum toxin type A-induced cleavage of SNAP-25 in rat cerebral synaptosome by toosendanin
Jian-Ying Zhou, Zhong-Feng Wang, Xiao-Mei Ren, Mian-Zhi Tang, Yu-Liang Shi · FEBS Letters · 2003 · in vitro
In vitro / animal · Verified
Rat cerebral synaptosomes preincubated with toosendanin, the marker limonoid of Melia bark, became completely resistant to botulinum neurotoxin A-mediated cleavage of SNAP-25, and toosendanin still partially antagonised the cleavage when added after the toxin had bound. This establishes the compound as a genuine presynaptic agent acting at the level of light-chain translocation, and is the mechanistic basis both for its use against experimental botulism and for the neuromuscular features of Melia poisoning.
Safety
Toxicity: toxic
Contraindications
Contraindicated in pregnancy and in hepatic impairment.
⚠ Rule-based cautions
These entries come from the deterministic rule tables that gate Verscienta's formula tools: classical pair prohibitions, pregnancy and lactation contraindications, dose ceilings, and drugs outside the Chinese Pharmacopoeia. The botanical-genus entries are different: advisory notes are not part of the safety screen; the Aristolochia genus check is.
Pregnancy
Avoid toxic
⚠ Toxicity
Compounds: Toosendanin and related limonoid triterpenes.
Symptoms
Nausea, vomiting, abdominal pain and dizziness; in overdose, hepatotoxicity and — reported in children — respiratory depression and death.
Cultural and historical
Shen Nong Ben Cao Jing · Han dynasty
References
- Wenxiang Fan, Linhong Fan, Zhengtao Wang, Li Yang. Limonoids From the Genus Melia (Meliaceae): Phytochemistry, Synthesis, Bioactivities, Pharmacokinetics, and Toxicology. Frontiers in Pharmacology. 2022 doi:10.3389/fphar.2021.795565
- Hui Chang, Chao Wang, Lili Gong, Yinghan Zhang, Conglian Liang, Hongyan Liu. An overview of Fructus Meliae Toosendan: Botany, traditional uses, phytochemistry, pharmacology and toxicology. Biomedicine & Pharmacotherapy. 2023 doi:10.1016/j.biopha.2022.113795